14 Results for "

primary hypertension

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "primary hypertension" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-12798
CAS No.: 1254032-66-0
Purity:  99.94%
Synonyms: AR-13324
Netarsudil (AR-13324) is a competitive inhibitor of Rho-associated protein kinases (ROCK I and ROCK II) and a reversible inhibitor of the norepinephrine transporter (NET). Netarsudil reduces intraocular pressure by inhibiting ROCK, causing relaxation of trabecular meshwork cells and dilation of episcleral veins, thereby increasing the ease of aqueous humor outflow, while inhibiting NET to reduce aqueous humor production. Netarsudil is mainly used in the study of ocular hypertension and primary open-angle glaucoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12798B
CAS No.: 1253952-02-1
Purity:  99.90%
Synonyms: AR-13324 hydrochloride
Target:  

ROCK

Netarsudil (AR-13324) hydrochloride is a competitive inhibitor of Rho-associated protein kinases (ROCK I and ROCK II) and a reversible inhibitor of the norepinephrine transporter (NET). Netarsudil hydrochloride reduces intraocular pressure by inhibiting ROCK, causing relaxation of trabecular meshwork cells and dilation of episcleral veins, thereby increasing the ease of aqueous humor outflow, while inhibiting NET to reduce aqueous humor production. Netarsudil hydrochloride is mainly used in the study of ocular hypertension and primary open-angle glaucoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12798A
CAS No.: 1422144-42-0
Purity:  99.90%
Synonyms: AR-13324 dimesylate
Target:  

ROCK

Netarsudil (AR-13324) dimesylate is a competitive inhibitor of Rho-associated protein kinases (ROCK I and ROCK II) and a reversible inhibitor of the norepinephrine transporter (NET). Netarsudil dimesylate reduces intraocular pressure by inhibiting ROCK, causing relaxation of trabecular meshwork cells and dilation of episcleral veins, thereby increasing the ease of aqueous humor outflow, while inhibiting NET to reduce aqueous humor production. Netarsudil dimesylate is mainly used in the study of ocular hypertension and primary open-angle glaucoma .
loading...
    loading...
Cat. No.: HY-129630
CAS No.: 53-02-1
Purity:  99.91%
Tetrahydrocortisol is a metabolite of Hydrocortisone (HY-N0583) that fails to activate glucocorticoid receptor. Tetrahydrocortisol inhibits Dexamethasone (HY-14648)-induced formation of cross-linked actin networks. Tetrahydrocortisol acts as a synergist to enhance the activity of anticancer agents. Tetrahydrocortisol can be used in the research of primary open-angle glaucoma, ocular hypertension, lung cancer and breast cancer .
loading...
    loading...
Cat. No.: HY-113986
CAS No.: 102676-87-9
Purity:  98.75%
Synonyms: (R)-Fadrozole; (R)-CGS 16949A free base; FAD286
Target:  

Cytochrome P450

Research Areas:  

Cardiovascular Disease

Dexfadrostat ((R)-Fadrozole) is an orally active and selective aromatase inhibitor, with human aromatase IC50 values of 6.4 nM. Dexfadrostat suppresses estrogen synthesis, reduces circulating estradiol levels and suppresses aldosterone production. Dexfadrostat can be used for the research of breast cancer, primary aldosteronism, and hypertension .
loading...
    loading...
Cat. No.: HY-118010A
CAS No.: 37936-89-3
Purity:  99.77%
Synonyms: d-Norfenfluramine hydrochloride
Target:  

5-HT Receptor

Research Areas:  

Cardiovascular Disease

(+)-Norfenfluramine hydrochloride, a major hepatic metabolite of (+)-fenfluramine, is a selective 5-HT2B receptor agonist (Ki: 11.2 nM). (+)-Norfenfluramine hydrochloride potently stimulates the hydrolysis of inositol phosphates and increases intracellular Ca 2+. (+)-Norfenfluramine hydrochloride can be used for the research of primary pulmonary hypertension and valvular heart disease .
loading...
    loading...
Cat. No.: HY-W131725
CAS No.: 19036-73-8
Synonyms: d-Norfenfluramine
Target:  

5-HT Receptor

Research Areas:  

Cardiovascular Disease

(+)-Norfenfluramine a major hepatic metabolite of (+)-fenfluramine, is a selective 5-HT2B receptor agonist (Ki: 11.2 nM). (+)-Norfenfluramine potently stimulates the hydrolysis of inositol phosphates and increases intracellular Ca 2+. (+)-Norfenfluramine can be used for the research of primary pulmonary hypertension and valvular heart disease .
loading...
    loading...
Cat. No.: HY-129630S
Purity:  99.19%
Tetrahydrocortisol-d5 is the deuterium labeled Tetrahydrocortisol. Tetrahydrocortisol is a metabolite of Hydrocortisone (HY-N0583) that fails to activate glucocorticoid receptor. Tetrahydrocortisol inhibits Dexamethasone (HY-14648)-induced formation of cross-linked actin networks. Tetrahydrocortisol acts as a synergist to enhance the activity of anticancer agents. Tetrahydrocortisol can be used in the research of primary open-angle glaucoma, ocular hypertension, lung cancer and breast cancer .
loading...
    loading...
Cat. No.: HY-106570
CAS No.: 73803-48-2
Target:  

Potassium Channel

Research Areas:  

Metabolic Disease

Tripamide is an orally active sulfonamide-derived diuretic antihypertensive agent .
loading...
    loading...
Cat. No.: HY-A0114
CAS No.: 103775-14-0
Synonyms: RS 10029
Moexiprilat is an inhibitor of angiotensin-converting enzyme (ACE; IC50=2.1 nM) and an active metabolite of the prodrug Moexipril (HY-117281). It is formed from moexipril in vivo by side chain ester hydrolysis. Moexiprilat (10 nM) prevents the estrone- or angiotensin II-stimulated proliferation of primary neonatal rat cardiac fibroblasts. It reduces mean arterial blood pressure and increases the levels of atrial natriuretic peptide, a marker of hypertension, in ovariectomized mice when administered at a dose of 50 mg/kg per day.
loading...
    loading...
Cat. No.: HY-113249
CAS No.: 3604-86-2
Target:  

Drug Metabolite

Aldosterone 18-glucuronide is a urinary metabolite of Aldosterone (HY-113313). It exhibits 100% specificity in distinguishing primary aldosteronism from essential hypertension, but has relatively low overall sensitivity. There is no difference in sensitivity of Aldosterone 18-glucuronide between hypokalemic and normokalemic primary aldosteronism. Aldosterone 18-glucuronide can be used for the research of primary aldosteronism .
loading...
    loading...
Cat. No.: HY-113986C
CAS No.: 131863-75-7
Synonyms: (R)-Fadrozole hydrochloride; (R)-CGS 16949A; FAD286 hydrochloride
Target:  

Cytochrome P450

Research Areas:  

Cardiovascular Disease Cancer

Dexfadrostat ((R)-Fadrozole) hydrochloride is an orally active and selective aromatase inhibitor, with human aromatase IC50 values of 6.4 nM. Dexfadrostat hydrochloride suppresses estrogen synthesis, reduces circulating estradiol levels and suppresses aldosterone production. Dexfadrostat hydrochloride can be used for the research of breast cancer, primary aldosteronism, and hypertension .
loading...
    loading...
Cat. No.: HY-L145
931 compounds

The majority of hypertensive patients have primary (or essential) hypertension, that is, hypertension in which secondary causes are not present. Management aims to control arterial pressure, prevent end-organ damage (cerebrovascular, cardiovascular, and renal), and reduce the risk of premature death.

Antihypertensive drugs may be divided into two broad groups, the first group being those which directly or indirectly block the renin–angiotensin system (RAS), for example, ACEIs, angiotensin receptor antagonists (ARAs), direct renin inhibitors (DRIs), and to a lesser extent β-blockers. The second group of drugs works by increasing water and sodium excretion, thereby reducing intravascular volume, or by causing vasodilatation through non-RAS pathways, for example, diuretics and calcium channel blockers (CCBs).

MCE offers a unique collection of 931 compounds with identified and potential antihypertensive activity. MCE Antihypertensive Compound Library is critical for antihypertensive drug discovery and development.

Cat. No.: HY-W343043
CAS No.: 60398-24-5
Synonyms: PZG
Target:  

Drug Derivative

Pyrazinoylguanidine (PZG) is an analogue of the potassium sparing diuretic, Amiloride (HY-B0285). Pyrazinoylguanidine can lower the systolic and diastolic blood pressure of patients with primary hypertension, has a certain effect on reducing heart rate, and does not affect the concentrations of electrolytes such as sodium, potassium, and chloride in the blood serum. Pyrazinoylguanidine can reduce the hyperglycemia and hyperinsulinemia in type 2 diabetes, reduce the levels of triglycerides, cholesterol, and free fatty acids, and reverse the hyperglycemia and hyperlipidemia induced by thiazide diuretics, such as Hydrochlorothiazide (HY-B0252). Pyrazinoylguanidine ican nhibit the reabsorption of urea by the renal tubules, thereby increasing the clearance rate and excretion volume of urea, reducing the serum urea concentration, and minimizing its toxic accumulation .
loading...
    loading...
  • 1